Janssen Claps Back At Challenge To Stelara Patent
Janssen Biotech Inc. has pushed back on claims from a subsidiary of Indian pharma giant Intas Pharmaceutical Ltd. that a patent for its blockbuster immunosuppressant Stelara should be revoked as intellectual...To view the full article, register now.
Already a subscriber? Click here to view full article